메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

Smartee Deepens Its Strategy for Central Asia and Russia in 2025

SHANGHAI, Nov. 20, 2025 -- Smartee Denti-Technology is reinforcing its international footprint with a focused strategy in Central Asia and Russia for 2025, cementing its position as a global leader in clear aligner and digital orthodontic technologies. This year, Smartee showcased its innovative orthodontic solutions at major regional exhibitions, including Dental Salon Moscow (April), Kazdent Expo Almaty and IDECA Tashkent (May), and Dental Expo Moscow and CADEX Almaty (September–October). These events underscored Smartee's expertise in digital orthodontics, highlighting its commitmen
- 김갑성 기자
- 2025-11-20 13:53
Remplir™ Nerve Sparing Prostate Cancer Surgery Commercial Opportunity Gathers Momentum with ~100 Surgeries Now Performed with Multiple Surgeons Nationwide

Company to invest in further research to strengthen clinical evidence ahead of medium-term U.S. launch with no further FDA approvals needed Adoption of Remplir™ among Australian urologists is accelerating, with ~100 surgeries conducted by surgeons nationwide. This promising new application for Remplir can potentially reduce post-surgical complications from peripheral nerve injury, representing a globally significant commercial opportunity for the Company. Despite advances such as nerve-sparing techniques and robotic-assisted radical prostatectomy (RARP), damage to the peripheral
- 김갑성 기자
- 2025-11-20 13:52
Antengene Hosts 2025 R&D Day Showcasing Encouraging Clinical Data and Solid Progress with Investigational Programs

SHANGHAI and HONG KONG, Nov. 20, 2025 -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercialising first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, announced that at the R&D Day taking place today, it will present the latest data and future plans for three mid/late-stage clinical programs, including ATG-022 (CLDN18.2 antibody-drug conjugate [ADC]), ATG-037 (oral CD73 small mo
- 김갑성 기자
- 2025-11-20 10:56
WuXi AppTec Receives Frost & Sullivan's 2025 Global Company of the Year Recognition in the CRDMO Industry

[ 메디채널 김갑성 기자 ] WuXi AppTec sets new benchmarks in strategic execution and technological advancement, further strengthening its ability to support innovators worldwide as they deliver breakthrough medicines for patients. SAN ANTONIO, Nov. 20, 2025 -- Frost & Sullivan is pleased to announce that WuXi AppTec has received the 2025 Global Company of the Year Recognition in the contract research, development, and manufacturing organization (CRDMO) industry for its outstanding achievements in enabling innovation, operational excellence, and customer impact. This recognition underscores
- 김갑성 기자
- 2025-11-20 10:00
Dr James Liang Launches HK$500 Million "Genovation Foundation" to Address Low Fertility

HONG KONG, Nov. 20, 2025 -- On World Children's Day, Dr James Liang, Co-founder of Trip.com Group, announced the establishment of the Genovation Foundation Limited in Hong Kong. Established in his personal capacity, the foundation pledges HK$500 million over five years to address declining fertility through three key avenues: economic subsidies, cultural advocacy, and policy research. The name Genovation combines "Gene" and "Innovation", symbolising both the continuity of life and the pursuit of creative solutions to pressing social challenges. This marks another si
- 김갑성 기자
- 2025-11-20 10:00
USANA Named No. 1 Dietary Supplements Brand in the Philippines for the 7th Consecutive Year

Euromonitor Recognizes USANA Philippines as the Market Leader from 2019 to 2025 MANILA, Philippines, Nov. 20, 2025 -- USANA Health Sciences, Inc., a global leader in health and wellness, has once again been recognized as the No. 1 dietary supplements brand in the Philippines* by Euromonitor International—marking an unprecedented seven consecutive years at the top (2019–2025). This continued recognition underscores USANA's unwavering commitment to delivering science-based nutrition, premium-quality products, and exceptional trust among Filipino consumers. &
- 김갑성 기자
- 2025-11-20 09:16
ZIRCON-X Analysis: TLX250-CDx Impacts Clinical Decision Making for Almost Half of Patients with Indeterminate Renal Masses

MELBOURNE, Australia and INDIANAPOLIS, Nov. 20, 2025 -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces results from the ZIRCON-X study which finds that almost half of all patients imaged with TLX250-CDx (Zircaix®[1], 89Zr-DFO-girentuximab) PET/CT[2] would have undergone a change in clinical management, when compared with baseline standard of care (SOC) imaging. The data will be presented at the 26th Annual Meeting of the Society of Urologic Oncology (SUO) being held in Phoenix, AZ, December 2 – 5, 2025. ZIRCON-X was a
- 김갑성 기자
- 2025-11-20 03:00
Dimora Medical Supports HS Connect Empower Workshop to Promote Science-Based Care for Hidradenitis Suppurativa Patients

NEW YORK, Nov. 20, 2025 -- Patient-centered nonprofit organization HS Connect recently hosted the Empower HS: Knowledge and Advocacy Workshop, an educational event designed to help individuals living with Hidradenitis Suppurativa (HS) and their caregivers gain the knowledge and confidence to advocate for themselves. Dimora Medical, a continuous innovator in high-end medical care supplies, supported the event through product donations, joining in the effort to enhance public understanding, improve patient self-management, and advance scientific wound care practices. The workshop
- 김갑성 기자
- 2025-11-20 01:48
NABR: CITES Standing Committee Issues Assessment of Long-Tailed Macaque Monkey Breeding Practices

WASHINGTON, Nov. 20, 2025 -- The Standing Committee of CITES, an international body responsible for monitoring trade in animal species, announced the results of its review of animal breeding practices in Cambodia, thanking Cambodia for providing extensive data and relying on science. The report, released on Nov. 12, 2025 in advance of an upcoming Standing Committee meeting, is available at https://cites.org/eng/sc/79/agenda-documents. Among other positive findings, the report states that Cambodia has customs and inspection procedures in place that are "well-coordinated and
- 김갑성 기자
- 2025-11-20 01:33
BestQool Announces Up to 21% Off Red Light Therapy Devices on Amazon for Black Friday

NEW YORK, Nov. 19, 2025 -- This Black Friday, BestQool invites everyone to pause, breathe, and take a moment for themselves. Even a brief daily red light therapy session can help relax muscles, refresh the skin, and ease the day's tension. To make at-home wellness more accessible, BestQool is launching its official Black Friday promotion on Amazon. From 12:00 AM PST on November 20, 2025 to 11:59 PM PST on December 1, 2025, customers can enjoy: 20% off all BestQool products on Amazon, and an exclusive 21% discount on three of the brand's best-selling high-performance mode
- 김갑성 기자
- 2025-11-19 23:04

이전

41 42 43 44 45 46 47 48 49 50

많이 본 기사

최근기사

2026-01-01_THU

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 01월 01일 22시 40분